-
1
-
-
0033584440
-
The prevalence of hepatitis C virus infection in the United States, 1988 through 1994
-
Alter MJ, Kruszon-Moran D, Nainan OV, et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 1994; 341: 556-62.
-
N Engl J Med
, vol.1994
, Issue.341
, pp. 556-562
-
-
Alter, M.J.1
Kruszon-Moran, D.2
Nainan, O.V.3
-
3
-
-
0033998786
-
The past incidence of hepatitis C virus infection: Implications for the future burden of chronic liver disease in the United States
-
Armstrong GL, Alter MJ, McQuillan GM, Margolis HS. The past incidence of hepatitis C virus infection: implications for the future burden of chronic liver disease in the United States. Hepatology 2000; 31: 777-82.
-
(2000)
Hepatology
, vol.31
, pp. 777-782
-
-
Armstrong, G.L.1
Alter, M.J.2
McQuillan, G.M.3
Margolis, H.S.4
-
4
-
-
0036828840
-
National institutes of health consensus conference: Management of hepatitis C
-
Seeff L, Hoofnagle JH. National institutes of health consensus conference: management of hepatitis C. Hepatology 2002; 36: S1-20.
-
(2002)
Hepatology
, vol.36
-
-
Seeff, L.1
Hoofnagle, J.H.2
-
5
-
-
65449152185
-
Telaprevir with peginterferon and ribavirin for chronic HCV genotype 1 infection
-
McHutchison JG, Everson GT, Gordon SC, et al. Telaprevir with peginterferon and ribavirin for chronic HCV genotype 1 infection. N Engl J Med 2009; 360: 1827-38.
-
(2009)
N Engl J Med
, vol.360
, pp. 1827-1838
-
-
McHutchison, J.G.1
Everson, G.T.2
Gordon, S.C.3
-
6
-
-
77950817619
-
Telaprevir for previously treated chronic HCV infection
-
McHutchison JG, Manns MP, Muir AJ, et al. Telaprevir for previously treated chronic HCV infection. N Engl J Med 2010; 362: 1292-303.
-
N Engl J Med
, vol.2010
, Issue.362
, pp. 1292-1303
-
-
McHutchison, J.G.1
Manns, M.P.2
Muir, A.J.3
-
7
-
-
38449091418
-
Sustained virologic response and clinical outcomes in patients with chronic hepatitis C and advanced fibrosis
-
Veldt BJ, Heathcote EJ, Wedemeyer H, et al. Sustained virologic response and clinical outcomes in patients with chronic hepatitis C and advanced fibrosis. Ann Intern Med 2007; 147: 677-84.
-
(2007)
Ann Intern Med
, vol.147
, pp. 677-684
-
-
Veldt, B.J.1
Heathcote, E.J.2
Wedemeyer, H.3
-
8
-
-
78649471873
-
Antiviral therapy for cirrhotic hepatitis C: Association with reduced hepatocellular carcinoma development and improved survival
-
Tokyo-Chiba Hepatitis Research Group
-
Shiratori Y, Ito Y, Yokosuka O, et al. Tokyo-Chiba Hepatitis Research Group. Antiviral therapy for cirrhotic hepatitis C: association with reduced hepatocellular carcinoma development and improved survival. Ann Intern Med 2005; 18: 142.
-
(2005)
Ann Intern Med
, vol.18
, pp. 142
-
-
Shiratori, Y.1
Ito, Y.2
Yokosuka, O.3
-
9
-
-
77954196543
-
Antiviral therapy for hepatitis C: Why are so few patients being treated?
-
Volk ML. Antiviral therapy for hepatitis C: why are so few patients being treated? J Antimicrob Chemother 2010; 65: 1327-9.
-
J Antimicrob Chemother
, vol.2010
, Issue.65
, pp. 1327-1329
-
-
Volk, M.L.1
-
10
-
-
42449150116
-
Barriers to hepatitis C virus treatment in a Canadian HIV-hepatitis C virus coinfection tertiary care clinic
-
McLaren M, Garber G, Cooper C. Barriers to hepatitis C virus treatment in a Canadian HIV-hepatitis C virus coinfection tertiary care clinic. Can J Gastroenterol 2008; 22: 133-7.
-
(2008)
Can J Gastroenterol
, vol.22
, pp. 133-137
-
-
McLaren, M.1
Garber, G.2
Cooper, C.3
-
11
-
-
22144463864
-
Barriers to accessing HIV / AIDS care in North Carolina: Rural and urban differences
-
Reif S, Golin CE, Smith SR. Barriers to accessing HIV / AIDS care in North Carolina: rural and urban differences. AIDS Care 2005; 17: 558-65.
-
(2005)
AIDS Care
, vol.17
, pp. 558-565
-
-
Reif, S.1
Golin, C.E.2
Smith, S.R.3
-
12
-
-
0037119025
-
Psychiatric illness and illicit drugs as barriers to hepatitis C treatment among HIV / hepatitis C virus coinfected individuals
-
Taylor LE, Costello T, Alt E, Yates G, Tashima K. Psychiatric illness and illicit drugs as barriers to hepatitis C treatment among HIV / hepatitis C virus coinfected individuals. AIDS 2002; 16: 1700-1.
-
(2002)
AIDS
, vol.16
, pp. 1700-1701
-
-
Taylor, L.E.1
Costello, T.2
Alt, E.3
Yates, G.4
Tashima, K.5
-
13
-
-
16844370262
-
Challenges in the treatment of patients coinfected with HIV and hepatitis C virus: Need for team care
-
Fleming CA, Tumilty S, Murray JE, Nunes D. Challenges in the treatment of patients coinfected with HIV and hepatitis C virus: need for team care. Clin Infect Dis 2005; 40(Suppl. 5): S349-54.
-
(2005)
Clin Infect Dis
, vol.40
, Issue.SUPPL. 5
-
-
Fleming, C.A.1
Tumilty, S.2
Murray, J.E.3
Nunes, D.4
-
14
-
-
16844384955
-
Overcoming barriers to prevention, care, and treatment of hepatitis C in illicit drug users
-
Edlin BR, Kresina TF, Raymond DB, et al. Overcoming barriers to prevention, care, and treatment of hepatitis C in illicit drug users. Clin Infect Dis 2005; 40: S276-85.
-
(2005)
Clin Infect Dis
, vol.40
-
-
Edlin, B.R.1
Kresina, T.F.2
Raymond, D.B.3
-
15
-
-
0035253612
-
Hepatitis C disease among injection drug users: Knowledge, perceived risk, and willingness to receive treatment
-
Stein MD, Maksad J, Clarke J. Hepatitis C disease among injection drug users: knowledge, perceived risk, and willingness to receive treatment. Drug Alcohol Depend 2001; 61: 211-5.
-
(2001)
Drug Alcohol Depend
, vol.61
, pp. 211-215
-
-
Stein, M.D.1
Maksad, J.2
Clarke, J.3
-
16
-
-
0031835292
-
Barriers to care among persons living with HIV / AIDS in urban and rural areas
-
Heckman TG, Somlai AM, Peters J, et al. Barriers to care among persons living with HIV / AIDS in urban and rural areas. AIDS Care 1998; 10: 365-75.
-
(1998)
AIDS Care
, vol.10
, pp. 365-375
-
-
Heckman, T.G.1
Somlai, A.M.2
Peters, J.3
-
17
-
-
23744484452
-
Barriers to the treatment of hepatitis C: Patient, provider, and system factors
-
Morrill JA, Shrestha M, Grant RW. Barriers to the treatment of hepatitis C: patient, provider, and system factors. J Gen Intern Med 2005; 20: 754-8.
-
(2005)
J Gen Intern Med
, vol.20
, pp. 754-758
-
-
Morrill, J.A.1
Shrestha, M.2
Grant, R.W.3
-
18
-
-
25644435773
-
The impact of barriers to hepatitis C virus treatment in recovering heroin users maintained on methadone
-
Sylvestre DL, Litwin AH, Clements BJ, Gourevitch MN. The impact of barriers to hepatitis C virus treatment in recovering heroin users maintained on methadone. J Subst Abuse Treat 2005; 29: 159-65.
-
(2005)
J Subst Abuse Treat
, vol.29
, pp. 159-165
-
-
Sylvestre, D.L.1
Litwin, A.H.2
Clements, B.J.3
Gourevitch, M.N.4
-
19
-
-
37049001443
-
Barriers associated with the treatment of hepatitis C virus infection among illicit drug users
-
Grebely J, Genoway KA, Raffa JD, et al. Barriers associated with the treatment of hepatitis C virus infection among illicit drug users. Drug Alcohol Depend 2008; 93: 141-7.
-
(2008)
Drug Alcohol Depend
, vol.93
, pp. 141-147
-
-
Grebely, J.1
Genoway, K.A.2
Raffa, J.D.3
-
20
-
-
33748164346
-
Social stigmatization and hepatitis C virus infection
-
Zacks S, Beavers K, Theodore D, et al. Social stigmatization and hepatitis C virus infection. J Clin Gastroenterol 2006; 40: 220-4.
-
(2006)
J Clin Gastroenterol
, vol.40
, pp. 220-224
-
-
Zacks, S.1
Beavers, K.2
Theodore, D.3
-
22
-
-
42949139729
-
Psychiatric symptoms during interferon treatment for hepatitis C: Experiences from a tertiary care hepatology centre
-
Evon DM, Verma A, Simpson K, Galanko JA, Dougherty KA, Fried MW. Psychiatric symptoms during interferon treatment for hepatitis C: experiences from a tertiary care hepatology centre. Aliment Pharmacol Ther 2008; 27: 1071-80.
-
(2008)
Aliment Pharmacol Ther
, vol.27
, pp. 1071-1080
-
-
Evon, D.M.1
Verma, A.2
Simpson, K.3
Galanko, J.A.4
Dougherty, K.A.5
Fried, M.W.6
-
23
-
-
33748168698
-
Interferoninduced depression in chronic hepatitis C: A review of its prevalence risk factors biology and treatment approaches
-
Asnis GM, De La GR. Interferoninduced depression in chronic hepatitis C: a review of its prevalence, risk factors, biology, and treatment approaches. J Clin Gastroenterol 2006; 40: 322-35.
-
(2006)
J Clin Gastroenterol
, vol.40
, pp. 322-335
-
-
Asnis, G.M.1
De La, G.R.2
-
24
-
-
0034495841
-
Depression, fatigue, and functional disability in patients with chronic hepatitis C
-
Dwight MM, Kowdley KV, Russo JE, Ciechanowski PS, Larson AM, Katon WJ. Depression, fatigue, and functional disability in patients with chronic hepatitis C. J Psychosom Res 2000; 49: 311-7.
-
(2000)
J Psychosom Res
, vol.49
, pp. 311-317
-
-
Dwight, M.M.1
Kowdley, K.V.2
Russo, J.E.3
Ciechanowski, P.S.4
Larson, A.M.5
Katon, W.J.6
-
26
-
-
27644531963
-
Depression and anxiety in patients with hepatitis C: Prevalence, detection rates and risk factors
-
Golden J, O'Dwyer AM, Conroy RM. Depression and anxiety in patients with hepatitis C: prevalence, detection rates and risk factors. Gen Hosp Psychiatry 2005; 27: 431-8.
-
(2005)
Gen Hosp Psychiatry
, vol.27
, pp. 431-438
-
-
Golden, J.1
O'Dwyer, A.M.2
Conroy, R.M.3
-
27
-
-
0032936222
-
The underrecognition and undertreatment of depression: What is the breadth and depth of the problem?
-
Davidson JR, Meltzer-Brody SE. The underrecognition and undertreatment of depression: what is the breadth and depth of the problem? J Clin Psychiatry 1999; 60 (Suppl. 7): 4-9.
-
(1999)
J Clin Psychiatry
, vol.60
, Issue.SUPPL. 7
, pp. 4-9
-
-
Davidson, J.R.1
Meltzer-Brody, S.E.2
-
28
-
-
33745940500
-
The mediating role of health beliefs in the relationship between depressive symptoms and medication adherence in persons with diabetes
-
Chao J, Nau DP, Aikens JE, Taylor SD. The mediating role of health beliefs in the relationship between depressive symptoms and medication adherence in persons with diabetes. Res Social Adm Pharm 2005; 1: 508-25.
-
(2005)
Res Social Adm Pharm
, vol.1
, pp. 508-525
-
-
Chao, J.1
Nau, D.P.2
Aikens, J.E.3
Taylor, S.D.4
-
30
-
-
0028272197
-
A multidimensional model of self-esteem in depression
-
Robert JE, Monroe SM. A multidimensional model of self-esteem in depression. Clin Psychol Rev 1994; 14: 161-81.
-
(1994)
Clin Psychol Rev
, vol.14
, pp. 161-181
-
-
Robert, J.E.1
Monroe, S.M.2
-
31
-
-
0030809504
-
Identification of patient attitudes and preferences regarding treatment of depression
-
Cooper-Patrick L, Powe NR, Jenckes MW, Gonzales JJ, Levine DM, Ford DE. Identification of patient attitudes and preferences regarding treatment of depression. J Gen Intern Med 1997; 12: 431-8.
-
(1997)
J Gen Intern Med
, vol.12
, pp. 431-438
-
-
Cooper-Patrick, L.1
Powe, N.R.2
Jenckes, M.W.3
Gonzales, J.J.4
Levine, D.M.5
Ford, D.E.6
-
32
-
-
54049099629
-
Introduction: Chronic medical conditions and depression
-
Kravitz RL, Ford DE. Introduction: chronic medical conditions and depression. Am J Med 2008; 121: S1-7.
-
(2008)
Am J Med
, vol.121
-
-
Kravitz, R.L.1
Ford, D.E.2
-
33
-
-
84965520932
-
The CES-D Scale: A selfreport depression scale for research in the general population
-
Radloff LS. The CES-D Scale: a selfreport depression scale for research in the general population. Appl Psychol Meas 1977; 1: 385-401.
-
(1977)
Appl Psychol Meas
, vol.1
, pp. 385-401
-
-
Radloff, L.S.1
-
34
-
-
0028347548
-
Screening for depression in well older adults: Evaluation of a short form of the CES-D (Center for Epidemiology Studies Depression Scale)
-
Andresen EM, Malmgren JA, Carter WB, Patrick DL. Screening for depression in well older adults: evaluation of a short form of the CES-D (Center for Epidemiology Studies Depression Scale). Am J Prev Med 1994; 10: 77-84.
-
(1994)
Am J Prev Med
, vol.10
, pp. 77-84
-
-
Andresen, E.M.1
Malmgren, J.A.2
Carter, W.B.3
Patrick, D.L.4
-
35
-
-
0036836096
-
Screening for depression in a hepatitis C population: The reliability and validity of the Center for Epidemiologic Studies Depression Scale (CES-D)
-
Clark CH, Mahoney JS, Clark DJ, Eriksen LR. Screening for depression in a hepatitis C population: the reliability and validity of the Center for Epidemiologic Studies Depression Scale (CES-D). J Adv Nurs 2002; 40: 361-9.
-
(2002)
J Adv Nurs
, vol.40
, pp. 361-369
-
-
Clark, C.H.1
Mahoney, J.S.2
Clark, D.J.3
Eriksen, L.R.4
-
36
-
-
1842620533
-
Screening for depressive symptoms among HCV-infected injection drug users: Examination of the utility of the CES-D and the Beck Depression Inventory
-
Golub ET, Latka M, Hagan H, et al. Screening for depressive symptoms among HCV-infected injection drug users: examination of the utility of the CES-D and the Beck Depression Inventory. J Urban Health 2004; 81: 278-90.
-
(2004)
J Urban Health
, vol.81
, pp. 278-290
-
-
Golub, E.T.1
Latka, M.2
Hagan, H.3
-
38
-
-
34848834562
-
High deferral rates and poorer treatment outcomes for HCV patients with psychiatric and substance use comorbidities
-
Evon DM, Verma A, Dougherty KA, et al. High deferral rates and poorer treatment outcomes for HCV patients with psychiatric and substance use comorbidities. Dig Dis Sci 2007; 52: 3251-8.
-
(2007)
Dig Dis Sci
, vol.52
, pp. 3251-3258
-
-
Evon, D.M.1
Verma, A.2
Dougherty, K.A.3
-
39
-
-
0037133079
-
Surprisingly small effect of antiviral treatment in patients with hepatitis C
-
Falck-Ytter Y, Kale H, Mullen KD, Sarbah SA, Sorescu L, McCullough AJ. Surprisingly small effect of antiviral treatment in patients with hepatitis C. Ann Intern Med 2002; 136: 288-92.
-
(2002)
Ann Intern Med
, vol.136
, pp. 288-292
-
-
Falck-Ytter, Y.1
Kale, H.2
Mullen, K.D.3
Sarbah, S.A.4
Sorescu, L.5
McCullough, A.J.6
-
41
-
-
17844398239
-
Social cognitive determinants of vaccination behavior against hepatitis B: An assessment among men who have sex with men
-
De Wit JB, Vet R, Schutten M, van Steenbergen J. Social cognitive determinants of vaccination behavior against hepatitis B: an assessment among men who have sex with men. Prev Med 2005; 40: 795-802.
-
(2005)
Prev Med
, vol.40
, pp. 795-802
-
-
De Wit, J.B.1
Vet, R.2
Schutten, M.3
Van Steenbergen, J.4
-
42
-
-
33845915386
-
AIDS health beliefs and intention for sexual abstinence among male adolescent students in Kathmandu, Nepal: A test of perceived severity and susceptibility
-
Iriyama S, Nakahara S, Jimba M, Ichikawa M, Wakai S. AIDS health beliefs and intention for sexual abstinence among male adolescent students in Kathmandu, Nepal: a test of perceived severity and susceptibility. Public Health 2007; 121: 64-72.
-
(2007)
Public Health
, vol.121
, pp. 64-72
-
-
Iriyama, S.1
Nakahara, S.2
Jimba, M.3
Ichikawa, M.4
Wakai, S.5
-
43
-
-
45849103112
-
Determinants of participation in cancer support groups: The role of health beliefs
-
Sherman AC, Pennington J, Simonton S, Latif U, Arent L, Farley H. Determinants of participation in cancer support groups: the role of health beliefs. Int J Behav Med 2008; 15: 92-100.
-
(2008)
Int J Behav Med
, vol.15
, pp. 92-100
-
-
Sherman, A.C.1
Pennington, J.2
Simonton, S.3
Latif, U.4
Arent, L.5
Farley, H.6
-
44
-
-
25644443975
-
Prospective multicenter study of eligibility for antiviral therapy among 4,084 U.S. veterans with chronic hepatitis C virus infection
-
Bini EJ, Brau N, Currie S, et al. Prospective multicenter study of eligibility for antiviral therapy among 4,084 U.S. veterans with chronic hepatitis C virus infection. Am J Gastroenterol 2005; 100: 1772-9.
-
(2005)
Am J Gastroenterol
, vol.100
, pp. 1772-1779
-
-
Bini, E.J.1
Brau, N.2
Currie, S.3
-
45
-
-
33644757488
-
Hepatitis C treatment eligibility and outcomes among patients with psychiatric illness
-
Rifai MA, Moles JK, Short DD. Hepatitis C treatment eligibility and outcomes among patients with psychiatric illness. Psychiatr Serv 2006; 57: 570-2.
-
(2006)
Psychiatr Serv
, vol.57
, pp. 570-572
-
-
Rifai, M.A.1
Moles, J.K.2
Short, D.D.3
-
46
-
-
77956643273
-
Expanding access to hepatitis C virus treatment-Extension for Community Healthcare Outcomes (ECHO) project: Disruptive innovation in specialty care
-
Arora S, Kalishman S, Thornton K, et al. Expanding access to hepatitis C virus treatment-Extension for Community Healthcare Outcomes (ECHO) project: disruptive innovation in specialty care. Hepatology 2010; 52: 1124-33.
-
Hepatology
, vol.2010
, Issue.52
, pp. 1124-1133
-
-
Arora, S.1
Kalishman, S.2
Thornton, K.3
|